RNA interference (RNAi) is a natural mechanism used by the body to turn genes off without permanently changing DNA. It controls how and when genes are turned into proteins and is part of the innate immune response to viruses. RNAi occurs when a small RNA (a microRNA, small interfering RNA or antisense RNA) binds to messenger RNA (mRNA) and stops it from being turned into a protein product.
RNAi can turn off any gene in the genome and so is used in scientific research to discover the genetic cause of different diseases and in RNA medicines to treat diseases caused by too much protein or by defective proteins.
May 15, 2017
Ernst & Young Selected Arcturus as the Finalists for the Entrepreneur Of The Year 2017 Award® in San Diego
April 29, 2017
Arcturus Therapeutics to Present at the TIDES--Oligonucleotides and Peptide Therapeutics, on Unlocked Nucleomonomer Agent (UNA) Oligomer System, Challenges and Opportunities
April 10, 2017
Arcturus Therapeutics is Selected by Ernst and Young as Semifinalists for the Entrepreneur Of The Year® 2017 Award in San Diego